Lawrence Einhorn MD

Dr. Lawrence Einhorn’s clinical interests include solid tumor oncology, specifically within the fields of genitourinary and lung cancers. His legacy will be forever linked, however, with revolutionizing testicular cancer treatment. At one point, patients diagnosed with testicular cancer had approximately a 10 percent chance of survival when they developed metastatic disease.

Dr. Einhorn’s research drastically altered this number when he first studied platinum combination chemotherapy in patients with metastatic testicular cancer. This monumental finding has resulted in current survival rates for metastatic testicular cancer at 80 percent.

Dr. Einhorn rose to even greater prominence when he used his novel treatment paradigm to treat Lance Armstrong, cancer advocate and seven-time winner of the Tour de France. With Dr. Einhorn’s treatment, Armstrong survived stage 3 testicular cancer that initially presented with abdominal, brain and lung metastases. Like Armstrong, Einhorn remains dedicated to raising cancer awareness. He was appointed the first Lance Armstrong Foundation professor of oncology in 2006. 

After receiving his medical degree from the University of Iowa, in Iowa City, Einhorn completed fellowships at The University of Texas MD Anderson Cancer Center in Houston, Texas, and the Indiana University Medical Center. Einhorn has published more than 450 peer-reviewed articles. His work has garnered many accolades, including AACR Richard and Hinda Rosenthal Memorial Award, ASCO Karnofsky Award, ACS Medal of Honor, and the General Motors Kettering Prize.  He is a member of the National Academy of Sciences and American Philosophical Society.